BioMarin Pharmaceuticals Appoints Arpit Davé as Chief Digital and Information Officer for Transformation

BioMarin Pharmaceuticals Appoints Chief Digital and Information Officer to Drive Digital Transformation

BioMarin Pharmaceutical Inc. announces the appointment of Arpit Davé as its Executive Vice President and Chief Digital and Information Officer. This newly created role, reporting directly to President and CEO Alexander Hardy, indicates the company’s commitment to enhancing its digital capabilities and operational efficiency. With over 20 years of experience in information technology and artificial intelligence within the biopharmaceutical sector, Davé aims to spearhead BioMarin's enterprise technology strategy and digital transformation initiatives. His extensive background, particularly in digital innovation at Amgen, positions him well to lead the company into a new era of data-driven decision-making and operational excellence.

In his previous role at Amgen, Davé was instrumental in driving digital transformation through the integration of advanced technologies. His tenure at Bristol Myers Squibb and Merck further solidifies his reputation as a seasoned executive in the field of CIO leadership and data science. At BioMarin, Davé intends to leverage his expertise to build a strategic vision that enhances operations across research, development, manufacturing, and commercial sectors. His focus on creating value for patients, employees, and shareholders aligns with BioMarin's mission to develop therapies for individuals with rare diseases and underscores the growing importance of technology in biopharmaceutical innovation.

Davé’s enthusiasm for BioMarin’s goals reflects a shared vision for the future of healthcare, where the intersection of biology, data, and artificial intelligence can significantly expedite the development and delivery of life-changing therapies. As the biopharmaceutical industry increasingly embraces digital solutions, BioMarin's strategic appointment indicates a proactive approach to harnessing technology for improved patient outcomes and operational efficiencies. Mr. Hardy commends Davé as a visionary leader who can effectively navigate the complexities of the industry while driving business growth through technological advancements.

In addition to his extensive professional background, Davé holds a Master’s degree in Industrial Engineering from the University of Texas and a Bachelor’s degree in Mechanical Engineering from S.P. University in India. His academic credentials complement his practical experience, equipping him with a robust foundation to tackle the challenges of digital transformation in the biopharmaceutical landscape.

This leadership transition comes at a pivotal moment for BioMarin as it seeks to navigate the rapid advancements in technology and biopharmaceutical research. By tapping into Davé’s expertise, the company aims to remain at the forefront of innovation while delivering on its commitment to patients with rare diseases.